Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
HSE SummitWebinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory
Commentaries

Subscribe

  • News
  • Watch
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Commentaries
  • Subscribe
  • ADHD
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • Bronchiectasis
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hidradenitis Suppurativa
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type 2 Diabetes
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
AMCP Nexus 2026|
HSES 2026
Advertisement

Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Advertisement

Articles by Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Celltrion USA’s commitment to meeting patient demand for affordable and effective biologics

ByThomas Nusbickel, Chief Commercial Officer, Celltrion USA
October 6th 2023

Sponsored Content

Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars

ByThomas Nusbickel, Chief Commercial Officer, Celltrion USA
July 5th 2023

Sponsored Content

Advertisement

Latest Updated Articles

  • Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars
    Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars

    July 5th 2023



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

Quick Q&A: Sarah Klein on scrutinizing PBM contracts

2

Closing rural maternity care gaps starts close to home, Centene and AAFP leaders say

3

Federal judge vacates HRSA limits on gender-affirming care in Ryan White HIV program

4

For transgender women with HIV, risk awareness and provider trust shape anal cancer follow-up

5

Bringing CAR T and bispecifics closer to home with Prerna Mewawalla, M.D.

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us